In a different and more provocative direction, Sorensen et al. have described naturally occurring anti-IDO2 immune responses in the peripheral blood of both cancer patients and healthy donors, specifically, in the presence of a spontaneous cytotoxic T-cell reactivity directed against the IDO2 protein that can recognize and destroy human tumor cells (39). This evidence concerns the gene IDO2 and cancer.